LCD Reference Article Response To Comments Article

Response to Comments: Transthoracic Echocardiography (TTE)

A59357

Expand All | Collapse All
Draft Article
Draft Articles are works in progress and not necessarily a reflection of the current billing and coding practices. Revisions to codes are carefully and thoroughly reviewed and are not intended to change the original intent of the LCD.

Document Note

Note History

Contractor Information

Article Information

General Information

Source Article ID
N/A
Article ID
A59357
Original ICD-9 Article ID
Not Applicable
Article Title
Response to Comments: Transthoracic Echocardiography (TTE)
Article Type
Response to Comments
Original Effective Date
04/13/2023
Revision Effective Date
N/A
Revision Ending Date
N/A
Retirement Date
N/A

CPT codes, descriptions, and other data only are copyright 2023 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

Current Dental Terminology © 2023 American Dental Association. All rights reserved.

Copyright © 2024, the American Hospital Association, Chicago, Illinois. Reproduced with permission. No portion of the AHA copyrighted materials contained within this publication may be copied without the express written consent of the AHA. AHA copyrighted materials including the UB‐04 codes and descriptions may not be removed, copied, or utilized within any software, product, service, solution, or derivative work without the written consent of the AHA. If an entity wishes to utilize any AHA materials, please contact the AHA at 312‐893‐6816.

Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions; and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only authorized with an express license from the American Hospital Association. The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. The views and/or positions presented in the material do not necessarily represent the views of the AHA. CMS and its products and services are not endorsed by the AHA or any of its affiliates.

CMS National Coverage Policy

N/A

Article Guidance

Article Text

Minor revision to existing policy, L34338 Transthoracic Echocardiography (TTE) - added Section on CAMZYOS™ (mavacamten) treatment which is for symptomatic obstructive hypertrophic cardiomyopathy NYHA Class II-III and can only be used as part of the CAMZYOS Risk Evaluation and Mitigation Strategy (REMS) program. 

This policy will be in notice April 13, 2023 thru May 27, 2023, becoming effective May 28, 2023.

Response To Comments

Number Comment Response
1

Bristol Myers Squibb (BMS) Bristol Myers Squibb (BMS) submitted the following “BMS supports Medicare policies that promote beneficiary access to new and effective medical treatments and ensures Medicare patients benefit from innovation that defines the US healthcare system… BMS applauds CGS’ decision to add section 19 (CAMZYOS™ (mavacamten) treatment) and the addition of paragraph #16 under LIMITATIONS to the LCD. We fully support the language contained in these sections of the proposed LCD and believe that it will ensure that Medicare beneficiaries with symptomatic obstructive hypertrophic cardiomyopathy will be treated in accordance with the CAMZYOS Risk Evaluation and Mitigation Strategy (REMS) program as required by the US Food and Drug Administration (FDA) and that those claims for transthoracic echocardiogram (TTE) will be appropriately adjudicated. BMS would like to thank CGS for this opportunity to comment on the Proposed LCD and appreciates its time and consideration.”

Thank you for your comments.

N/A

Coding Information

Bill Type Codes

Code Description

Please accept the License to see the codes.

N/A

Revenue Codes

Code Description

Please accept the License to see the codes.

N/A

CPT/HCPCS Codes

Please accept the License to see the codes.

N/A

CPT/HCPCS Modifiers

Group 1

Group 1 Paragraph

N/A

Group 1 Codes

N/A

N/A

ICD-10-CM Codes that Support Medical Necessity

Group 1

Group 1 Paragraph

N/A

Group 1 Codes

N/A

N/A

ICD-10-CM Codes that DO NOT Support Medical Necessity

Group 1

Group 1 Paragraph

N/A

Group 1 Codes

N/A

N/A

ICD-10-PCS Codes

Group 1

Group 1 Paragraph

N/A

Group 1 Codes

N/A

N/A

Additional ICD-10 Information

Bill Type Codes

Code Description

Please accept the License to see the codes.

N/A

Revenue Codes

Code Description

Please accept the License to see the codes.

N/A

Other Coding Information

Group 1

Group 1 Paragraph

N/A

Group 1 Codes

N/A

N/A

Coding Table Information

Excluded CPT/HCPCS Codes - Table Format
Code Descriptor Generic Name Descriptor Brand Name Exclusion Effective Date Exclusion End Date Reason for Exclusion
N/A N/A
N/A
Non-Excluded CPT/HCPCS Ended Codes - Table Format
Code Descriptor Generic Name Descriptor Brand Name Exclusion Effective Date Exclusion End Date Reason for Exclusion
N/A

Revision History Information

Revision History Date Revision History Number Revision History Explanation
N/A

Associated Documents

Medicare BPM Ch 15.50.2 SAD Determinations
Medicare BPM Ch 15.50.2
Related Local Coverage Documents
LCDs
L34338 - Transthoracic Echocardiography (TTE)
Related National Coverage Documents
N/A
SAD Process URL 1
N/A
SAD Process URL 2
N/A
Statutory Requirements URLs
N/A
Rules and Regulations URLs
N/A
CMS Manual Explanations URLs
N/A
Other URLs
N/A
Public Versions
Updated On Effective Dates Status
04/06/2023 04/13/2023 - N/A Currently in Effect You are here

Keywords

N/A